Our findings thus highlight these age- and organ-specific differences in AATD pathophysiology and indicate that C-terminal AAT-derived peptides may serve as promising candidate markers for monitoring liver status in children, potentially providing complementary information to conventional laboratory measures of total AAT. The gene discussed is SERPINA1; the disease is alpha 1-antitrypsin deficiency.